- Home
- ENTA vs CNTY Comparison
ENTA vs CNTY Comparison
Compare ENTA & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- CNTY
- Stock Information
- Founded
- ENTA 1995
- CNTY 1992
- Country
- ENTA United States
- CNTY United States
- Employees
- ENTA N/A
- CNTY N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- CNTY Hotels/Resorts
- Sector
- ENTA Health Care
- CNTY Consumer Discretionary
- Exchange
- ENTA Nasdaq
- CNTY Nasdaq
- Market Cap
- ENTA 127.8M
- CNTY 120.3M
- IPO Year
- ENTA 2013
- CNTY 1993
- Fundamental
- Price
- ENTA $6.28
- CNTY $3.45
- Analyst Decision
- ENTA Buy
- CNTY Strong Buy
- Analyst Count
- ENTA 4
- CNTY 4
- Target Price
- ENTA $19.50
- CNTY $5.50
- AVG Volume (30 Days)
- ENTA 537.1K
- CNTY 97.6K
- Earning Date
- ENTA 02-05-2025
- CNTY 11-04-2024
- Dividend Yield
- ENTA N/A
- CNTY N/A
- EPS Growth
- ENTA N/A
- CNTY N/A
- EPS
- ENTA N/A
- CNTY N/A
- Revenue
- ENTA $67,635,000.00
- CNTY $581,905,000.00
- Revenue This Year
- ENTA $11.80
- CNTY $8.07
- Revenue Next Year
- ENTA $3.99
- CNTY $9.46
- P/E Ratio
- ENTA N/A
- CNTY N/A
- Revenue Growth
- ENTA N/A
- CNTY 14.05
- 52 Week Low
- ENTA $5.70
- CNTY $1.94
- 52 Week High
- ENTA $17.80
- CNTY $5.09
- Technical
- Relative Strength Index (RSI)
- ENTA 31.04
- CNTY 34.89
- Support Level
- ENTA $5.70
- CNTY $3.35
- Resistance Level
- ENTA $6.56
- CNTY $4.00
- Average True Range (ATR)
- ENTA 0.74
- CNTY 0.16
- MACD
- ENTA -0.11
- CNTY -0.10
- Stochastic Oscillator
- ENTA 14.91
- CNTY 12.50
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurant, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.